The addition of zoledronic acid to combination chemotherapy decreases circulating serum levels of vascular endothelial growth factor (VEGF) in early breast cancer

✍ Scribed by M.C. Winter*; A. Evans; I. Holen; R.E. Coleman

• Book ID: 116324003
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 69 KB
• Volume: 48
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2010.10.082